Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'Not a methamphetamine' OR with Authors including 'Not a methamphetamine' OR with Abstract including 'Not a methamphetamine' OR with Keywords including 'Not a methamphetamine'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Norton S Behavioral patterns as a technique for studying psychotropic drugs. Psychotropic drugs. 1957
Gujral ML, Dhawan BN Effects of drugs on LSD-25 induced pyrexia in rabbits. Indian J.Physiol.Pha... 1959
Dhawan BN Effect of drugs on LSD-25 induced pyrexia in rabbits. Arch.internat.de pha... 1959
Ling TM, Buckman J The use of lysergic acid in individual psychotherapy Proc. roy. Soc. Med. 1960
Biered J, Browne IW An experiment with a psychiatric night hospital Proc. Roy. Soc. Med. 1960
Gupta GP, Dhawan BN Blockade of reserpine emesis in pigeons Arch. int. pharmacod... 1960
Fuller RW, Hines CW, Mill... Lowering of Brain Serotonin Levels by Chloramphetamines Biochem Pharmacol 1965
Gaston TR, Rasmussen GT Identification of 3,4 methylenedioxymethamphetamine Bureau of Narcotics ... 1972
Yamada K, Ogawa N, Gomita... State-Dependent Learning (Dissociation of Learning) with Hallucinogens... Jap.Pharmacol. 1973
Caldwell J, Sever PS The biochemical pharmacology of abused drugs 1. Amphetamines, cocaine,... Clin.Pharmacol.Ther. 1974
Pieri L, Pieri M Drug-induced Rotation in Rats after Unilateral Intracerebral Injection... Experientia 1974
Pieri L, Pieri M, Haefely... LSD as an agonist dopamine receptors in the striatum Nature 1974
Kelly PH Action of LSD on supersensitive mesolimic dopamine receptors British J.Pharmac. 1975
Pieri M, Pieri L, Saner A... A Comparison of Drug-induced rotation in rats lesioned in the Medial F... Arch. int. Pharmacod... 1975
Gershon MD, Robinson RG, ... Serotonin Accumulation in the Guinea-Pig Myenteric Plexus: Ion Depende... J.Pharmacol.Exp.Ther... 1976
Greenblatt DJ, Allen MD, ... Accidental Poisoning with Psychotropic Drugs in Children. Am.J.Dis.Child. 1976
Martin P, Consroe P Cannabinoid Induced Behavioral Convulsions in Rabbits Science 1976
Smith JM, Misiak H Critical Flicker Frequency (CFF) and Psychotropic Drugs in Normal Huma... Psychopharmacology 1976
Frischknecht HR, Waser PG Actions of Hallucinogens on Ants (Formica Pratensis)-II. Effects of Am... Gen.Pharmacol. 1978
Da Prada M, Pieri L, Kell... Effects of 5,6-Dihydroxytryptamine and 5,7-Dihydroxytryptamine on the ... Ann.N.Y.Acad.Sci. 1978
Decker WJ, Brandes WB LSD Misadventure in Middle Age J. Forens. Sci. 1978
Schmidt CJ, Sonsalla PK, ... Methamphetamine-induced depression of monoamine synthesis in the rat: ... J Neurochem 1985
Riedlinger JE The scheduling of MDMA: a pharmacist's perspective J Psychoactive Drugs 1985
Renfroe CL, Messinger TA Street drug analysis: an eleven year perspective on illicit drug alter... Semin Adolesc Med 1985
Beck J MDMA: The popularization and resultant implications of a recently cont... Contemporary Drug Pr... 1986
Grinspoon L, Bakalar JB Can drugs be used to enhance the psychotherapeutic process? Am J Psychother 1986
Lyon RA, Glennon RA, Tite... 3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions... Psychopharmacology (... 1986
Stone DM, Stahl DC, Hanso... The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... Eur J Pharmacol 1986
Glennon RA, Yousif M, Nai... Methcathinone: a new and potent amphetamine-like agent Pharmacol Biochem Be... 1987
Dowling GP, McDonough ET ... 'Eve' and 'Ecstasy'. A report of five deaths associated with the use o... JAMA 1987
Frith CH, Chang LW, Latti... Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the ra... Fundam Appl Toxicol 1987
Gibb JW, Stone DM, Stahl ... The effects of amphetamine-like designer drugs on monoaminergic system... NIDA Res Monogr 1987
Mokler DJ, Robinson SE, R... (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reduc... Eur J Pharmacol 1987
Peroutka SJ, Pascoe N, Fa... Monoamine metabolites in the cerebralspinal fluid of recreational user... Research Comm in Sub... 1987
Smilkstein MJ, Smolinske ... A case of MAO inhibitor/MDMA interaction: agony after ecstasy J Toxicol Clin Toxic... 1987
Stone DM, Hanson GR, Gibb... Differences in the central serotonergic effects of methylenedioxymetha... Neuropharmacology 1987
Stone DM, Johnson M, Hans... A comparison of the neurotoxic potential of methylenedioxyamphetamine ... Eur J Pharmacol 1987
Stone DM, Merchant KM, Ha... Immediate and long-term effects of 3,4-methylenedioxymethamphetamine o... Neuropharmacology 1987
Wang SS, Ricaurte GA, Per... [3H]3,4-methylenedioxymethamphetamine (MDMA) interactions with brain m... Eur J Pharmacol 1987
Callahan PM, Appel JB Differences in the stimulus properties of 3,4-methylenedioxyamphetamin... J Pharmacol Exp Ther 1988
Johnson M, Hanson GR, Gib... Effects of dopaminergic and serotonergic receptor blockade on neuroche... Neuropharmacology 1988
Nash JF Jr, Meltzer HY, G... Elevation of serum prolactin and corticosterone concentrations in the ... J Pharmacol Exp Ther 1988
Nencini P, Woolverton WL,... Enhancement of morphine-induced analgesia after repeated injections of... Brain Res 1988
Oberlender R, Nichols DE Drug discrimination studies with MDMA and amphetamine Psychopharmacology (... 1988
Peroutka SJ, Newman H, Ha... Subjective effects of 3,4-methylenedioxymethamphetamine in recreationa... Neuropsychopharmacol... 1988
Ramos JM Jr, Fitzgerald R... MDMA and MDA cross reactivity observed with Abbott TDx amphetamine/met... Clin Chem 1988
Ricaurte GA, Forno LS, Wi... (+/-)3,4-Methylenedioxymethamphetamine selectively damages central ser... JAMA 1988
Schechter MD Use of TFMPP stimulus properties as a model of 5-HT1B receptor activat... Pharmacol Biochem Be... 1988
Price LH, Ricaurte GA, Kr... Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-m... Arch Gen Psychiatry 1989
Gollamudi R, Ali SF, Lipe... Influence of inducers and inhibitors on the metabolism in vitro and ne... Neurotoxicology 1989
Hekmatpanah CR, McKenna D... Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced n... Neurosci Lett 1989
Insel TR, Battaglia G, Jo... 3,4-Methylenedioxymethamphetamine ('ecstasy') selectively destroys bra... J Pharmacol Exp Ther 1989
Johnson M, Hanson GR, Gib... Effect of MK-801 on the decrease in tryptophan hydroxylase induced by ... Eur J Pharmacol 1989
Johnson M, Stone DM, Bush... Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... Eur J Pharmacol 1989
Kelland MD, Freeman AS, C... (+/-)-3,4-Methylenedioxymethamphetamine-induced changes in the basal a... Eur J Pharmacol 1989
Kleven MS, Woolverton WL,... Evidence that both intragastric and subcutaneous administration of met... Brain Res 1989
Li AA, Marek GJ, Vosmer G... Long-term central 5-HT depletions resulting from repeated administrati... Pharmacol Biochem Be... 1989
Lowy MT, Nash JF Jr, Melt... Selective reduction of striatal type II glucocorticoid receptors in ra... Eur J Pharmacol 1989
Mansbach RS, Braff DL, Ge... Prepulse inhibition of the acoustic startle response is disrupted by N... Eur J Pharmacol 1989
Matthews RT, Champney TH,... Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopam... Pharmacol Biochem Be... 1989
Nader MA, Hoffmann SM, Ba... Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-... Psychopharmacology (... 1989
Nichols DE, Oberlender R Structure-activity relationships of MDMA-like substances NIDA Res Monogr 1989
Price LH, Ricaurte GA, Kr... Responses to I.V. L-tryptophan in MDMA Users NIDA Res Monogr 1989
Slikker W Jr, Holson RR, ... Behavioral and neurochemical effects of orally administered MDMA in th... Neurotoxicology 1989
Steele TD, Nichols DE, Yi... MDMA transiently alters biogenic amines and metabolites in mouse brain... Pharmacol Biochem Be... 1989
Stone DM, Hanson GR, Gibb... In vitro reactivation of rat cortical tryptophan hydroxylase following... J Neurochem 1989
Stone DM, Johnson M, Hans... Acute inactivation of tryptophan hydroxylase by amphetamine analogs in... Eur J Pharmacol 1989
Bilsky EJ, Hui YZ, Hubbel... Methylenedioxymethamphetamine's capacity to establish place preference... Pharmacol Biochem Be... 1990
Callaway CW, Wing LL, Gey... Serotonin release contributes to the locomotor stimulant effects of 3,... J Pharmacol Exp Ther 1990
Finnegan KT, Skratt JJ, I... The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prev... Neurosci Lett 1990
Fitzgerald JL, Reid JJ Effects of methylenedioxymethamphetamine on the release of monoamines ... Eur J Pharmacol 1990
Gaylor DW, Slikker W Jr Risk assessment for neurotoxic effects Neurotoxicology 1990
Grob C, Bravo G, Walsh R Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxic... Arch Gen Psychiatry 1990
Hashimoto K, Goromaru T Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-m... Neuropharmacology 1990
Hiramatsu M, Cho AK Enantiomeric differences in the effects of 3,4-methylenedioxymethamphe... Neuropharmacology 1990
Hiramatsu M, Kumagai Y, U... Metabolism of methylenedioxymethamphetamine: formation of dihydroxymet... J Pharmacol Exp Ther 1990
Nichols DE, Oberlender R Structure-activity relationships of MDMA and related compounds: a new ... Ann N Y Acad Sci 1990
Oberlender R, Nichols DE (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative... J Pharmacol Exp Ther 1990
Ricaurte GA, Finnegan KT,... Aminergic metabolites in cerebrospinal fluid of humans previously expo... Ann N Y Acad Sci 1990
Scheffel U, Ricaurte GA Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamin... Brain Res 1990
Schmidt CJ, Abbate GM, Bl... Selective 5-hydroxytryptamine2 receptor antagonists protect against th... J Pharmacol Exp Ther 1990
Schmidt CJ, Black CK, Abb... Chloral hydrate anesthesia antagonizes the neurotoxicity of 3,4-methyl... Eur J Pharmacol 1990
Schmidt CJ, Black CK, Abb... Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity a... Brain Res 1990
Winslow JT, Insel TR Serotonergic modulation of rat pup ultrasonic vocal development: studi... J Pharmacol Exp Ther 1990
Zacny JP, Virus RM, Woolv... Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MD... Pharmacol Biochem Be... 1990
Greer GR,Tolbert R The Therapeutic Use of MDMA Ecstasy: The clinica... 1990
Chiang CN, Hawks RL Research Findings on Smoking of Abused Substances NIDA Research Monogr... 1990
McKenna DJ, Guan XM, Shul... 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... Pharmacol Biochem Be... 1991
Paris JM, Cunningham KA Lack of Neurotoxicity after Intra-Raphe Micro-Injections of MDMA ('Ecs... NIDA Res Monogr 1991
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Battaglia G, Sharkey J, K... Neuroanatomic specificity and time course of alterations in rat brain ... Synapse 1991
Bilsky EJ, Hubbell CL, De... MDMA produces a conditioned place preference and elicits ejaculation i... Pharmacol Biochem Be... 1991
Callaway CW, Johnson MP, ... Amphetamine derivatives induce locomotor hyperactivity by acting as in... Psychopharmacology (... 1991
Champney TH, Matthews RT Pineal serotonin is resistant to depletion by serotonergic neurotoxins... J Pineal Res 1991
Dragunow M, Logan B, Lave... 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat bas... Eur J Pharmacol 1991
Hiramatsu M, DiStefano E,... A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effect... Eur J Pharmacol 1991
Millan MJ, Colpaert FC Methylenedioxymethamphetamine induces spontaneous tail-flicks in the r... Eur J Pharmacol 1991
Pan HS, Wang RY The action of (+/-)-MDMA on medial prefrontal cortical neurons is medi... Brain Res 1991
Pan HS, Wang RY MDMA: further evidence that its action in the medial prefrontal cortex... Brain Res 1991
Schmidt CJ, Taylor VL, Ab... 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-m... J Pharmacol Exp Ther 1991

Page 1 of 7   /   608 Entries Returned
Pages:     
 1 
2 3 4 5 6 7 next